OBJECTIVE: We describe the design and methods of the Aging, Demographics, and Memory Study (ADAMS), a new national study that will provide data on the antecedents, prevalence, outcomes, and costs of dementia and "cognitive impairment, not demented" (CIND) using a unique study design based on the nationally representative Health and Retirement Study (HRS). We also illustrate potential uses of the ADAMS data and provide information to interested researchers on obtaining ADAMS and HRS data. METHODS: The ADAMS is the first population-based study of dementia in the United States to include subjects from all regions of the country, while at the same time using a single standardized diagnostic protocol in a community-based sample. A sample of 856 individuals age 70 or older who were participants in the ongoing HRS received an extensive in-home clinical and neuropsychological assessment to determine a diagnosis of normal, CIND, or dementia. Within the CIND and dementia categories, subcategories (e.g. Alzheimer's disease, vascular dementia) were assigned to denote the etiology of cognitive impairment. CONCLUSION: Linking the ADAMS dementia clinical assessment data to the wealth of available longitudinal HRS data on health, health care utilization, informal care, and economic resources and behavior, will provide a unique opportunity to study the onset of CIND and dementia in a nationally representative population-based sample, as well as the risk factors, prevalence, outcomes, and costs of CIND and dementia. Copyright (c) 2005 S. Karger AG, Basel.
OBJECTIVE: We describe the design and methods of the Aging, Demographics, and Memory Study (ADAMS), a new national study that will provide data on the antecedents, prevalence, outcomes, and costs of dementia and "cognitive impairment, not demented" (CIND) using a unique study design based on the nationally representative Health and Retirement Study (HRS). We also illustrate potential uses of the ADAMS data and provide information to interested researchers on obtaining ADAMS and HRS data. METHODS: The ADAMS is the first population-based study of dementia in the United States to include subjects from all regions of the country, while at the same time using a single standardized diagnostic protocol in a community-based sample. A sample of 856 individuals age 70 or older who were participants in the ongoing HRS received an extensive in-home clinical and neuropsychological assessment to determine a diagnosis of normal, CIND, or dementia. Within the CIND and dementia categories, subcategories (e.g. Alzheimer's disease, vascular dementia) were assigned to denote the etiology of cognitive impairment. CONCLUSION: Linking the ADAMS dementia clinical assessment data to the wealth of available longitudinal HRS data on health, health care utilization, informal care, and economic resources and behavior, will provide a unique opportunity to study the onset of CIND and dementia in a nationally representative population-based sample, as well as the risk factors, prevalence, outcomes, and costs of CIND and dementia. Copyright (c) 2005 S. Karger AG, Basel.
Authors: YongJoo Rhee; John G Csernansky; Linda L Emanuel; Chang-Gok Chang; Joseph W Shega Journal: J Am Geriatr Soc Date: 2011-09-23 Impact factor: 5.562
Authors: Toru Okura; Brenda L Plassman; David C Steffens; David J Llewellyn; Guy G Potter; Kenneth M Langa Journal: J Am Geriatr Soc Date: 2010-01-26 Impact factor: 5.562
Authors: Esther M Friedman; Margaret M Weden; Regina A Shih; Stephanie Kovalchik; Reema Singh; Jose Escarce Journal: J Gerontol B Psychol Sci Soc Sci Date: 2015-10-08 Impact factor: 4.077
Authors: Pei-Jung Lin; Joanna Emerson; Jessica D Faul; Joshua T Cohen; Peter J Neumann; Howard M Fillit; Allan T Daly; Nikoletta Margaretos; Karen M Freund Journal: J Am Geriatr Soc Date: 2020-04-13 Impact factor: 5.562
Authors: Mary A M Rogers; Brenda L Plassman; Mohammed Kabeto; Gwenith G Fisher; John J McArdle; David J Llewellyn; Guy G Potter; Kenneth M Langa Journal: J Geriatr Psychiatry Neurol Date: 2008-12-10 Impact factor: 2.680
Authors: Dimitry S Davydow; Catherine L Hough; Deborah A Levine; Kenneth M Langa; Theodore J Iwashyna Journal: Am J Med Date: 2013-03-14 Impact factor: 4.965